Drug Information Association Logo
Corporate Tagline

THE EUROPEAN LANDSCAPE ON HTA - THE EUnetHTA JOINT ACTION

Track:
HTA/Sustainability of Health Systems in Europe

Day & Time:
March 5, 11:00AM - 12:30PM

Session Number:
0102

Room Number:
G107

Type:
Session

Title:
THE EUROPEAN LANDSCAPE ON HTA - THE EUnetHTA JOINT ACTION

Chair(s):
Finn Boerlum Kristensen, MD,PhD
Director Coordinating Secretariat EUnetHTA Executve Committee
Danish Health and Medicines Authority, Denmark

Description:
The aim of this session is to introduce the current scenarios of HTA in the European context. In particular, three points of view are considered as significant in order to match the highest purposes of dissemination of HTA methods and finalities: the status of the European Network for Health Technology Assessment (EUnetHTA) Joint Action, one of the most collaborative experiences among stakeholders in Europe, the engagement of industry as key partner for institutions to have results in terms of improved medicines and sustainability for healthcare systems and the perspective of patients as the final target of a complex and challenging process.

Presentation(s) & Speaker(s):
The European landscape on HTA – Update on the EUnetHTA Joint Action
Finn Boerlum Kristensen, MD,PhD
Director Coordinating Secretariat EUnetHTA Executve Committee
Danish Health and Medicines Authority, Denmark

Improving Collaboration between Industry and Regulatory world: HTA as a pivotal challenge to match wider needs
Richard Bergstroem, MS
Director-General
EFPIA, Belgium

The Patients’ Perception about the Regulatory World: Experience in the field
Eric Low
Chief Executive
Myeloma UK, United Kingdom

© 2013 DIA